Leonteq Securities AG (Guernsey Branch) Share Price

Certificat

CH1254833770

Market Closed - Deutsche Boerse AG 08:58:02 01/07/2024 pm IST
1,035 EUR +0.54% Intraday chart for Leonteq Securities AG (Guernsey Branch)
Current month+0.54%
1 month+3.69%
Date Price Change
01/24/01 1,035 +0.54%
28/24/28 1,030 -0.13%
27/24/27 1,031 +0.21%
26/24/26 1,029 -0.38%
25/24/25 1,033 -0.18%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 08:58 pm IST

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer LEONTEQ
WKN A33D76
ISINCH1254833770
Date issued 22/03/2023
Strike 264.2 CHF
Maturity 15/03/2027 (987 Days)
Parity 0.26 : 1
Emission price 1,000
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 1,105
Lowest since issue 813.6
Spread 7.79
Spread %0.75%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
250.1 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.18%
Consensus